MEDIPHARM WORLDWIDE GROUP
ActiveMEDIPHARM WORLDWIDE GROUP has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €218k and a net result of €168k. Its solvency ranks better than 73% of 60 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
84
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency91
Growth-
Track record67
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days only on tighter terms
Liquidity ample (current ratio 2.36; short-term debt: 34.2% and cash: 34.3% of total assets), and 34.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
65.8%
Return on assets
50.7%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-08-2026, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filingDeviation from the deadline
2025
29 d late
← before the deadline
after the deadline →
Financials · fiscal year 2025, micro schema
Equity
€218k
Total assets
€331k
Net result
€168k
Working capital
€154k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Assets €331k
Fixed assets
€64k
Current assets
€267k
Equity and liabilities €331k
Equity
€218k
Debt
€113k
Debt finances 34.2% of the balance-sheet total.
Key figures and ratios
Solvency
65.8%
Current ratio
2.36
Quick ratio
2.36
Debt / equity
0.52
ROE
77.1%
ROA
50.7%
Debt
€113k
Debt ≤ 1 year
€113k
Income taxes
€50k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Assets
Total assets20/58€331k
Fixed assets21/28€64k
Tangible fixed assets22/27€64k
Furniture and vehicles24€64k
Current assets29/58€267k
Amounts receivable within one year40/41€154k
Trade receivables40€104k
Other amounts receivable41€50k
Cash at bank and in hand54/58€113k
Equity and liabilities
Total equity and liabilities10/49€331k
Equity10/15€218k
Contributions10/11€50k
Profit (loss) carried forward14€168k
Amounts payable17/49€113k
Amounts payable within one year42/48€113k
Trade debts44€17k
Suppliers440/4€17k
Taxes, remuneration and social security45€64k
Taxes450/3€64k
Other amounts payable47/48€32k
Income statement
Code2025
Other operating charges640/8€26k
Non-recurring operating charges66A€883
Gross operating margin9900€247k
Operating profit (loss)9901€220k
Financial charges65/66B€2k
Recurring financial charges65€2k
Profit (loss) for the period before taxes9903€218k
Income taxes67/77€50k
Profit (loss) for the period9904€168k
Profit (loss) for the period to be appropriated9905€168k
Appropriation of the result
Profit (loss) to be appropriated9906€168k
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
29-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 29 days late
NBB filing
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tienen · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Leuvensestraat 1313300 TienenGround area
1,577 m²
Building footprint
544 m²
Volume, LiDAR
2,110 m³
2 parcels, Flanders, Wallonia · tallest building 11.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
MEDIPHARM WORLDWIDE GROUP
since 20242.368.822.449
2 parcels
Flanders
1
(50%)
Wallonia
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25764O0217/00H000 | Wallonia | 1,176 m² | 1 · 169 m² | - |
| 24593G0715/00A000 | Flanders | 401 m² | 1 · 375 m² | 11.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMA MAR
BE 0634.863.713
Brussel · Eq €223k
TAKEAIR
BE 0658.744.222
Oudenaarde · Eq €226k
MAKE IT WORK CONSULTING
BE 0784.837.589
Villers-la-Ville · Eq €210k
Plant Bio Technologies
BE 0537.556.083
Gent · Eq €240k
NO HEADACHE
BE 0430.126.506
Elsene · Eq €192k
Of 148 companies in sector 21100 we hold annual accounts for 108. 70 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded24-12-2024
Fiscal year end31-12
Abbreviation NL
MWG
Activities, NACEBEL
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods
70200Business and other management consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.